110 results on '"Massie, Barry M."'
Search Results
2. Effects of the Adenosine A1 Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction: Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function)
3. The Effects of KW-3902, an Adenosine A1-Receptor Antagonist,on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure and Renal Impairment or Diuretic Resistance
4. Effects of Multiple Oral Doses of an A1Adenosine Antagonist, BG9928, in Patients With Heart Failure: Results of a Placebo-Controlled, Dose-Escalation Study
5. Utility of Impedance Cardiography for the Identification of Short-Term Risk of Clinical Decompensation in Stable Patients With Chronic Heart Failure
6. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure
7. Effect of Beta-Blockade on Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Clinical Trials 11All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California San Francisco
8. Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure
9. National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities
10. The Predictive Value of Short-Term Changes in Hemoglobin Concentration in Patients Presenting With Acute Decompensated Heart Failure
11. Globalization of Clinical Trials
12. Reply
13. Heart Failure Guidelines, Performance Measures, and the Practice of Medicine
14. BASELINE SYSTOLIC BLOOD PRESSURE AND OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION - RESULTS FROM THE I-PRESERVE TRIAL
15. ACUTE CORONARY SYNDROMES IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: A HARBINGER OF DEATH?
16. Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
17. Aspirin Use in Chronic Heart Failure
18. Natriuretic peptide measurements for the diagnosis of “nonsystolic” heart failure
19. Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting
20. Carvedilol initiation by community physicians in COHORE: comparison with U.S. carvedilol trials and compassionate use protocols
21. Strategies to improve guideline adherence: a randomized clinical trial
22. Neurohormonal blockade in chronic heart failure
23. Differences Between Primary Care Physicians and Cardiologists in Management of Congestive Heart Failure: Relation to Practice Guidelines 11This work was supported in part by unrestricted grants from Bristol-Myers Squibb Co., Princeton, New Jersey; Burroughs Wellcome Co., Research Triangle Park, North Carolina; Merck & Co., West Point, Pennsylvania; and the Department of Veterans Affairs Research Service.22All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California in San Francisco.
24. Ischemic vs non ischemic cardiomyopathy: Clinical outcome and response to amiodarone
25. Differences in practice patterns in managing of heart failure between cardiologists, family practitioners, and internists
26. Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure
27. Exercise intolerance in chronic heart failure is not associated with impaired recovery of muscle function or submaximal exercise performance
28. 789-6 The 9-Minute Self-Powered Treadmill: Is It an Index of Submaximal Exercise Capacity in CHF?
29. 933-100 Effect of 6 Antihypertensive Drugs on ECG Left Ventricular Hypertrophy
30. 788-5 Does Abnormal Recovery of Skeletal Muscle Contribute to Fatigue During Repetitive Activities in CHF?
31. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension
32. Scintigraphic and electrocardiographic evidence of silent coronary artery disease in asymptomatic hypertension: A case-control study
33. Assessment of perioperative risk: Have we put the cart before the horse?
34. Reply
35. What is the role of silent coronary artery disease and left ventricular hypertrophy in the genesis of ventricular arrhythmias in men with essential hypertension?
36. Neurohormonal blockade in chronic heart failure How much is enough? can there be too much?∗∗Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology
37. Aspirin Use in Chronic Heart Failure What Should We Recommend to the Practitioner?
38. Effects of the Adenosine A1 Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function)
39. Natriuretic peptide measurements for the diagnosis of 'nonsystolic' heart failure Good news and bad**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology
40. Effects of Multiple Oral Doses of an A1Adenosine Antagonist, BG9928, in Patients With Heart Failure Results of a Placebo-Controlled, Dose-Escalation Study
41. Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure
42. Intertest variability of echocardiographic and chest X-Ray measurements: Implications for dDecision making in patients with aortic regurgitation
43. Improved regional ventricular function after successful surgical revascularization
44. Quantitative analysis of seven-pinhole tomographic thallium-201 scintigrams: Improved sensitivity and estimation of the extent of coronary involvement by evaluation of radiotracer uptake and clearance
45. Two-dimensional echocardiographic evaluation of the size, function and shape of the left ventricle in chronic aortic regurgitation: Comparison with radionuclide angiography
46. Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure
47. I. Introduction
48. 821-3 Evaluation of beta-blocker does in community-based treatment of heart failure
49. 821-2 Characteristics of heart failure patients in clinical practice: How do they relate to ejection fraction?
50. 1172-70 Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: Insights from a large prospective beta-blocker registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.